Physician profile
Sonika Gupta
NPI 1437105715
$5,491.56
in general payments reported to CMS, 2019-2025
9 companies · $193 in 2025
The $193 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2021: $19.95 · 2022: $177 · 2023: $600 · 2024: $4,356 · 2025: $193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,600 · Consulting Fee: $1,200 · Food and Beverage: $349.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,600.00 |
| Consulting Fee | $1,200.00 |
| Food and Beverage | $348.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Echosens North America, INC. | $4,800.00 | 2023-2024 | Fibroscan |
| Abbott Laboratories | $265.20 | 2022-2025 | Freestyle Libre 3 |
| Novo Nordisk INC | $121.39 | 2022 | |
| Dexcom, INC. | $95.69 | 2024 | Dexcom G6 Transmitter |
| Novartis Pharmaceuticals Corporation | $69.00 | 2019 | |
| Mannkind Corporation | $59.40 | 2019 | |
| Lilly USA, LLC | $34.16 | 2019-2022 | |
| Medtronic, INC. | $26.77 | 2022 | |
| Esperion Therapeutics, INC. | $19.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonika Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.